临床荟萃
• 专题 • 上一篇 下一篇
出版日期:
发布日期:
通讯作者:
作者简介:
Online:
Published:
Contact:
摘要： 华氏巨球蛋白血症（Waldenstrm’s macroglobulinemia, WM）/淋巴浆细胞淋巴瘤 （lymphoplasmacytic lymphoma, LPL）是一种少见的惰性B细胞非霍奇金淋巴瘤，该病临床以淋巴浆细胞骨髓、脏器浸润和血清单克隆免疫球蛋白M水平升高为特点。近年来，随着免疫学、分子遗传学的发展，以及新药的不断涌现，WM/LPL 的诊断与治疗取得了较大的进展，本文将对WM/LPL 的诊断与治疗进行相关综述。
关键词: Waldenstrom巨球蛋白血症, 淋巴瘤, , 小细胞, 免疫球蛋白M
Abstract: Waldenstrm's macroglobulinemia (WM)/lymphoplasmictic lymphoma (LPL) is a rare, incurable Bcell lymphoma. Its clinical course is characterized by elevated immunoglobulinM (IgM) levels, lymphoplasmacytic bone marrow infiltration with cytopenia, hepatomegaly, splenomegaly, and lymphadenopathy.Recently, great progress has been made to better explain the pathobiology of WM, which has identified several clinical and genetic markers that serve prognosticate disease course and patient outcomes. This article reviews some of the recent advance with respect to prognostic markers and new treatments that are currently in progress.
Key words: Waldenstrm macroglobulinemia, lymphoplasm, , smallcell, immunoglobulin M
李丽丽，刘沁华，夏瑞祥. 华氏巨球蛋白血症诊断和治疗[J]. 临床荟萃, doi: 10.3969/j.issn.1004-583X.2019.06.002.
Li Lili, Liu Qinhua, Xia Ruixiang. Diagnosis and treatment of Waldenstrm's macroglobulinaemia[J]. Clinical Focus, doi: 10.3969/j.issn.1004-583X.2019.06.002.
导出引用管理器 EndNote|Ris|BibTeX
链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2019.06.002
https://huicui.hebmu.edu.cn/CN/Y2019/V34/I6/489
